Metro-Minnesota Community Clinical Oncology Program

明尼苏达都会区社区临床肿瘤学计划

• 批准号: 8478047
• 负责人: Joseph Leach
• 金额: $ 250.6万
• 依托单位: PARK NICOLLET INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8478047
• 关键词: Adjuvant; American Cancer Society; Area; Award; Awareness; Back; Cancer Center; Cancer Control; Cancer Information Service; Cancer Patient; Cancer Trials Support Unit; Chemoprevention; Clinical; Clinical Oncology; Clinical Research; Clinical Trials; Clinics and Hospitals; Communication; Communities; Community Clinical Oncology Program; Community Hospitals; Community Physician; Comprehensive Cancer Center of Wake Forest University; Controlled Clinical Trials; Data; Data Collection; Doctor of Medicine; Eastern Cooperative Oncology Group; Enrollment; Environment; Evaluation; Family Practice; Funding; Future; Goals; Grant; Growth; Gynecologic Oncology; Gynecologic Oncology Group; Health; Health Care Reform; Health Planning; Health Planning Councils; Health Professional; Hematology; Hospital Administration; Hospitals; Improve Access; Institutes; Institution; Institutional Review Boards; Internal Medicine; Intestinal Cancer; Knowledge; Link; Malignant Neoplasms; Marketing; Medical Oncology; Minnesota; Minority; Modeling; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Neurology; North Central Cancer Treatment Group; Nursing Societies; Oncologic Nursing; Oncologist; Oncology Group; Oncology Nurse; Operations Research; Operative Surgical Procedures; Pamphlets; Participant; Patient Recruitments; Patients; Physicians; Prevention Protocols; Primary Care Physician; Principal Investigator; Protocols documentation; Quality of life; Radiation Oncology; Radiation Therapy Oncology Group; Recording of previous events; Reporting; Research; Research Design; Research Personnel; Resources; Specialist; Surgical Oncology; Surgical Specialties; System; Thoracic Surgical Procedures; Time; Toxic effect; Underrepresented Minority; Universities; Urology; base; cancer care; cancer prevention; cancer therapy; data management; follow-up; improved; malignant breast neoplasm; meetings; member; oncology; oncology program; organizational structure; programs; protocol development; research and development; research study; success; symptom management; web site

DESCRIPTION (provided by applicant): The Metro-Minnesota Community Clinical Oncology (MMCCOP) program has a long-standing history which clearly demonstrates the success of the consortium as demonstrated by the both the ongoing commitment of the original consortium members and the growth of the consortium from 1979 through 2009. The MMCCOP consortium represents an established community program base which began in 1979 through its NCI-funded Community Hospital Cancer Program (CHCP) Award. This program would have a major impact on the way that cancer care is delivered in the community and provided the cornerstone for this CCOP initiative. This same consortium applied for and received the initial Community Clinical Oncology Program (CCOP) grant from the NCI in 1983, and has received subsequent CCOP grants since that time in 1987, 1990, 1995, and 2000 and 2005. Currently, the MMCCOP consortium represents twelve hospital and clinics with a common approach and established mechanisms for identifying, enrolling and following participants on NCI sponsored treatment, cancer prevention and cancer control protocols. The health market In the MMCCOP community remains extremely competitive and is in constant change as a result of mergers and Minnesota's healthcare reform. Despite this changing environment, the MMCCOP hospitals and associated staff continue to collaborate and support the added time and expense Involved In clinical research trials. Their level of support has not been cut back, and In fact has increased, during a time when many other projects within the hospitals are being reduced or eliminated. This program incorporates a substantial segment of the practicing physician community, and has provided a basis for communications between the practicing oncologists, their hospital administrations, and other health professionals in this consortium for the past twenty-five years. Combined, the consortium members see an average of nearly 12,000 new analytic cancer patients per year. Currently, there are 110 Investigators, representing medical, radiation and surgical oncology Including neuro-surgery, thoracic surgery and gynecologic oncology, and hematology, urology, oncology, neurology, ENT, family practice and Internal medicine. The history of MMCCOP Research Base Affiliations and proactive approach to expanding access to NCI sponsored studies supports the ability to achieve and maintain the NCI goals for the CCOP Initiative. MMCCOP intends to sustain a region wide community consortium which provides the community with the most recent advances in cancer prevention, treatment and symptom management. This will be accomplished through continued affiliations with CTSU, ECOG, NCCTG, GOG, MD Anderson, NSABP, RTOG, URCC and CCCWFU, the expansion of the current MMCCOP data management and communication system to increase the number and level of participation of the investigators In accrual, program operations and research base activities, implementation of new strategies to improve access and participation of minority and underserved groups, and increase the professional and lay community awareness of the CCOP and benefits of clinical cancer trials. In addition, all member and affiliate institutions of both Metro-MN CCOP and MN CGOP research programs are members of the Institutional Review Board for the Community Oncology Programs, administered by Park Nicollet Institute. The application is submitted as MMCCOP completes Grant Year 26 with one of most successful years since initiation of this consortium program. During the most recent NCI-Funded grant (6/05-5/09), 242 credits (235 patients) were accrued to NCI- approved treatment studies and 372.8 credits (396 new patients and follow-up of 370 participants) were accrued to approved cancer control protocols. MMCCCOP has demonstrated the ability to enter an increasing number of patients on protocol each year and proposes to accrue a total of 240 credits to Treatment studies and 350 Cancer Control credits in the first year of this award with the goal of continually exceeding the NCI requirements for both types of studies.

描述（由申请人提供）：Metro-Minnesota社区临床肿瘤学（MMCCOP）项目有着悠久的历史，从最初的联盟成员的持续承诺和从1979年到2009年的联盟发展来看，这清楚地表明了联盟的成功。MMCCOP联盟代表了一个已建立的社区项目基础，该项目始于1979年，由nci资助的社区医院癌症项目（CHCP）奖。该项目将对社区提供癌症治疗的方式产生重大影响，并为CCOP倡议提供基石。该联盟于1983年申请并获得了NCI最初的社区临床肿瘤项目（CCOP）资助，并于1987年、1990年、1995年、2000年和2005年获得了后续的CCOP资助。目前，MMCCOP联盟代表12家医院和诊所，采用共同的方法和建立的机制来识别、登记和跟踪NCI赞助的治疗、癌症预防和癌症控制方案的参与者。健康市场在MMCCOP社区仍然极具竞争力，并在不断变化的合并和明尼苏达州的医疗改革的结果。尽管环境不断变化，MMCCOP医院和相关工作人员继续合作，并支持临床研究试验所涉及的额外时间和费用。在医院内的许多其他项目正在减少或取消的时候，它们的支持水平并没有减少，实际上还增加了。在过去的25年里，该项目包含了执业医师社区的大部分成员，并为执业肿瘤学家、医院管理部门和该联盟的其他卫生专业人员之间的交流提供了基础。联合起来，联盟成员平均每年有近12000名新的分析性癌症患者。目前，有110名研究人员，代表医学、放射和外科肿瘤学，包括神经外科、胸外科和妇科肿瘤学，以及血液学、泌尿外科、肿瘤学、神经病学、耳鼻喉科、家庭医学和内科。MMCCOP研究基地附属机构的历史和扩大NCI赞助研究的积极方法支持了实现和维持NCI CCOP倡议目标的能力。MMCCOP打算维持一个区域范围的社区联盟，为社区提供癌症预防、治疗和症状管理方面的最新进展。这将通过与CTSU、ECOG、NCCTG、GOG、MD Anderson、NSABP、RTOG、URCC和CCCWFU的持续合作来实现，扩展当前的MMCCOP数据管理和通信系统，以增加研究人员参与的数量和水平，项目运营和研究基地活动，实施新战略以改善少数民族和服务不足群体的访问和参与，并提高专业人士和非专业人士对CCOP和临床癌症试验益处的认识。此外，Metro-MN CCOP和MN CGOP研究项目的所有成员和附属机构都是社区肿瘤学项目机构审查委员会的成员，该委员会由Park Nicollet研究所管理。申请提交之际，MMCCOP完成了第26年的资助，这是自该联盟项目启动以来最成功的一年之一。在最近一次NCI资助的拨款期间（6/05-5/09），242个学分（235名患者）累积到NCI批准的治疗研究中，372.8个学分（396名新患者和370名参与者的随访）累积到批准的癌症控制方案中。MMCCCOP已经证明，每年有越来越多的患者进入方案，并计划在该奖项的第一年累计240个治疗研究学分和350个癌症控制学分，目标是不断超过NCI对这两类研究的要求。